Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 1
Submit an article Journal homepage
600
Views
5
CrossRef citations to date
0
Altmetric
Author's View

Reviving virus based cancer vaccines by using cytomegalovirus vectors expressing modified tumor antigens

Zhijuan QiuDepartment of Immunology
,
Jeremy M GrenierDepartment of Immunology
&
Kamal M KhannaDepartment of Immunology;Department of Pediatrics; University of Connecticut Health Center; Farmington, CTUSACorrespondence[email protected]
Article: e1056974 | Received 20 May 2015, Accepted 27 May 2015, Published online: 30 Nov 2015

References

  • Couzin-Frankel J. Breakthrough of the year 2013. Cancer immunotherapy. Science 2013; 342:1432-3; PMID:24357284; http://dx.doi.org/10.1126/science.342.6165.1432
  • Ott PA, Fritsch EF, Wu CJ, Dranoff G. Vaccines and melanoma. Hematol Oncol Clin North Am 2014; 28:559-69; PMID:24880947; http://dx.doi:org/10.1016/j.hoc.2014.02.008
  • Butterfield LH. Cancer vaccines. BMJ 2015; 350:h988; PMID:25904595; http://dx.doi.org/10.1136/bmj.h988
  • Qiu Z, Huang H, Grenier JM, Perez OA, Smilowitz HM, Adler B, Khanna KM. Cytomegalovirus-based vaccine expressing a modified tumor antigen induces potent tumor-specific CD8+ T-cell response and protects mice from melanoma. Cancer Immunol Res 2015; 3:536-46; PMID:25633711; http://dx.doi.org/10.1158/2326-6066.CIR-14-0044
  • Snyder CM, Cho KS, Bonnett EL, van DS, Shellam GR, Hill AB. Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 2008; 29:650-9; PMID:18957267; http://dx.doi.org/10.1016/j.immuni.2008.07.017
  • Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science 2015; 348:69-74; PMID: 25838375; http://dx.doi.org/10.1126/science.aaa4971
  • Van Stipdonk MJ, Badia-Martinez D, Sluijter M, Offringa R, van HT, Achour A. Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100. Cancer Res 2009; 69:7784-92; PMID:19789338; http://dx.doi.org/10.1158/0008-5472.CAN-09-1724
  • Xu G, Smith T, Grey F, Hill AB. Cytomegalovirus-based cancer vaccines expressing TRP2 induce rejection of melanoma in mice. Biochem Biophys Res Commun 2013; 437:287-91; PMID:23811402; http://dx.doi.org/10.1016/j.bbrc.2013.06.068
  • Duan F, Duitama J, Al SS, Ayres CM, Corcelli SA, Pawashe AP, Blanchard T, McMahon D, Sidney J, Sette A et al. Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity. J Exp Med 2014; 211:2231-48; PMID:25245761; http://dx.doi.org/10.1084/jem.20141308
  • Hansen SG, Powers CJ, Richards R, Ventura AB, Ford JC, Siess D, Axthelm MK, Nelson JA, Jarvis MA, Picker LJ et al. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 2010; 328: 102-6; PMID:20360110; http://dx.doi.org/10.1126/science.1185350

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.